179 related articles for article (PubMed ID: 35146989)
1. The classification of neuroendocrine neoplasms of the lung and digestive system according to WHO, 5th edition: similarities, differences, challenges, and unmet needs.
Sanguedolce F; Zanelli M; Palicelli A; Cavazza A; DE Marco L; Zizzo M; Ascani S; Landriscina M; Giordano G; Sollitto F; Loizzi D
Panminerva Med; 2022 Jun; 64(2):259-264. PubMed ID: 35146989
[TBL] [Abstract][Full Text] [Related]
2. Lung and digestive neuroendocrine neoplasms. From WHO classification to biomarker screening: Which perspectives?
Scoazec JY
Ann Endocrinol (Paris); 2019 Jun; 80(3):163-165. PubMed ID: 31064659
[TBL] [Abstract][Full Text] [Related]
3. Aspects regarding nomenclature, classification and pathology of neuroendocrine neoplasms of the digestive system - a review.
Păun I; Becheanu G; Costin AI; Constantin VD; Mihai GM; Radu L; Iovan L; Vârcuş F
Rom J Morphol Embryol; 2018; 59(3):673-678. PubMed ID: 30534804
[TBL] [Abstract][Full Text] [Related]
4. Relation between WHO Classification and Location- and Functionality-Based Classifications of Neuroendocrine Neoplasms of the Digestive Tract.
Helderman NC; Suerink M; Kilinç G; van den Berg JG; Nielsen M; Tesselaar MET
Neuroendocrinology; 2024; 114(2):120-133. PubMed ID: 37690447
[TBL] [Abstract][Full Text] [Related]
5. The classification of neuroendocrine neoplasms of the breast and its clinical relevance.
Uccella S
Virchows Arch; 2022 Jul; 481(1):3-12. PubMed ID: 34698887
[TBL] [Abstract][Full Text] [Related]
6. [The new WHO classification of digestive neuroendocrine tumors].
Scoazec JY; Couvelard A;
Ann Pathol; 2011 Apr; 31(2):88-92. PubMed ID: 21601112
[TBL] [Abstract][Full Text] [Related]
7. Digestive neuroendocrine tumors: reclassifying of 26 cases according to 2010 who classification.
Chaabane A; M'sakni I; Laabidi B; Bougrine F; Bouziani A
Tunis Med; 2016 Oct; 94(10):580-586. PubMed ID: 28972248
[TBL] [Abstract][Full Text] [Related]
8. Digestive neuroendocrine tumors: reclassifying of 26 cases according to 2010 who classification.
Chaabane A; M'sakni I; Laabidi B; Bougrine F; Bouziani A
Tunis Med; 2016 Oct; 94(8-9):580-586. PubMed ID: 28685792
[TBL] [Abstract][Full Text] [Related]
9. World Health Organization grading classification for pancreatic neuroendocrine neoplasms: a comprehensive analysis from a large Chinese institution.
Yang M; Zeng L; Ke NW; Tan CL; Tian BL; Liu XB; Xiang B; Zhang Y
BMC Cancer; 2020 Sep; 20(1):906. PubMed ID: 32962649
[TBL] [Abstract][Full Text] [Related]
10. [Trends in gastroenteropancreatic neuroendocrine tumors].
Kajiwara H; Osamura Y
Nihon Geka Gakkai Zasshi; 2008 May; 109(3):123-7. PubMed ID: 18536314
[TBL] [Abstract][Full Text] [Related]
11. Genomic Profiles and Current Therapeutic Agents in Neuroendocrine Neoplasms.
Ohmoto A; Morizane C
Curr Drug Targets; 2020; 21(4):389-405. PubMed ID: 31633473
[TBL] [Abstract][Full Text] [Related]
12. What is New in the 2019 World Health Organization (WHO) Classification of Tumors of the Digestive System: Review of Selected Updates on Neuroendocrine Neoplasms, Appendiceal Tumors, and Molecular Testing.
Assarzadegan N; Montgomery E
Arch Pathol Lab Med; 2021 Jun; 145(6):664-677. PubMed ID: 32233993
[TBL] [Abstract][Full Text] [Related]
13. Digestive neuroendocrine neoplasms: A 2016 overview.
Merola E; Rinzivillo M; Cicchese N; Capurso G; Panzuto F; Delle Fave G
Dig Liver Dis; 2016 Aug; 48(8):829-35. PubMed ID: 27212431
[TBL] [Abstract][Full Text] [Related]
14. Peptide Receptor Radionuclide Therapy in Grade 3 Neuroendocrine Neoplasms: Safety and Survival Analysis in 69 Patients.
Zhang J; Kulkarni HR; Singh A; Niepsch K; Müller D; Baum RP
J Nucl Med; 2019 Mar; 60(3):377-385. PubMed ID: 30115686
[TBL] [Abstract][Full Text] [Related]
15. Neuroendocrine Tumor Heterogeneity Adds Uncertainty to the World Health Organization 2010 Classification: Real-World Data from the Spanish Tumor Registry (R-GETNE).
Nuñez-Valdovinos B; Carmona-Bayonas A; Jimenez-Fonseca P; Capdevila J; Castaño-Pascual Á; Benavent M; Pi Barrio JJ; Teule A; Alonso V; Custodio A; Marazuela M; Segura Á; Beguiristain A; Llanos M; Martinez Del Prado MP; Diaz-Perez JA; Castellano D; Sevilla I; Lopez C; Alonso T; Garcia-Carbonero R
Oncologist; 2018 Apr; 23(4):422-432. PubMed ID: 29330208
[TBL] [Abstract][Full Text] [Related]
16. [WHO Classification of digestive tumors: the fourth edition].
Fléjou JF
Ann Pathol; 2011 Nov; 31(5 Suppl):S27-31. PubMed ID: 22054452
[No Abstract] [Full Text] [Related]
17. [The latest 2010 WHO classification of tumors of digestive system].
Li ZS; Li Q
Zhonghua Bing Li Xue Za Zhi; 2011 May; 40(5):351-4. PubMed ID: 21756837
[No Abstract] [Full Text] [Related]
18. Unmet Medical Needs in Metastatic Lung and Digestive Neuroendocrine Neoplasms.
Capdevila J; Bodei L; Davies P; Gorbounova V; Jensen RT; Knigge UP; Krejs GJ; Krenning E; O'Connor JM; Peeters M; Rindi G; Salazar R; Vullierme MP; Pavel ME; ;
Neuroendocrinology; 2019; 108(1):18-25. PubMed ID: 30153686
[TBL] [Abstract][Full Text] [Related]
19. The 2010 WHO classification of digestive neuroendocrine neoplasms: a critical appraisal four years after its introduction.
Rindi G; Petrone G; Inzani F
Endocr Pathol; 2014 Jun; 25(2):186-92. PubMed ID: 24699927
[TBL] [Abstract][Full Text] [Related]
20. Peritoneal Carcinomatosis in Gastro-Entero-Pancreatic Neuroendocrine Neoplasms: Clinical Impact and Effectiveness of the Available Therapeutic Options.
Merola E; Prasad V; Pascher A; Pape UF; Arsenic R; Denecke T; Fehrenbach U; Wiedenmann B; Pavel ME
Neuroendocrinology; 2020; 110(6):517-524. PubMed ID: 31484182
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
